🇺🇸 FDA
Patent

US 6054442

Methods and compositions for modulation and inhibition of telomerase in vitro

expired A61KA61K31/7064A61K31/7068

Quick answer

US patent 6054442 (Methods and compositions for modulation and inhibition of telomerase in vitro) held by The Board of Regents of the University of Texas System expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7064, A61K31/7068, A61K31/7072, A61K31/7076